3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, B-Cell
17
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma, Non-Hodgkin
12
Recurrence
11
Burkitt Lymphoma
10
Multiple Myeloma
7
Lymphoma
7
Neoplasms
6
Leukemia, Myeloid, Acute
6
Lymphoma, Mantle-Cell
5
Leukemia
5
Pancreatic Neoplasms
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Carcinoma, Hepatocellular
4
Neoplasm, Residual
3
Nasopharyngeal Carcinoma
3
Leukemia, B-Cell
3
Glioma
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Simpson-Golabi-Behmel syndrome
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Melanoma
2
Lymphoma, B-Cell, Marginal Zone
2
Interventions
Cyclophosphamide
53
Etoposide
33
Temozolomide
28
Irinotecan
28
Melphalan
25
Filgrastim
25
Topotecan
24
Carboplatin
24
3-Iodobenzylguanidine
23
Isotretinoin
20
Granulocyte Colony-Stimulating Factor
17
sargramostim
16
humanized 3F8 anti-GD2 monoclonal antibody
16
dinutuximab
16
Granulocyte-Macrophage Colony-Stimulating Factor
16
fludarabine
15
Vincristine
15
Doxorubicin
15
Cisplatin
15
Peripheral Blood Stem Cell Transplantation
14
Interleukin-2
14
Busulfan
13
naxitamab
12
Thiotepa
12
Radiotherapy
12
aldesleukin
11
fludarabine phosphate
10
etoposide phosphate
8
Mesna
8
Ifosfamide
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroblastoma
×
Immunotherapy, Adoptive
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts